5Badesch DB, Abman SH, Ahearn GS, et al. Medical therapy for pulmonary arterial hypertension: ACCP evidence-hased clinical practice guidelindes. Chest, 2004, 126: 35S. 被引量：1
6Siobal MS. Pulmonary vasodilators. Respir Care, 2007,52: 885. 被引量：1
7Reeves JT. High adventure in pulmonary hypertension: acute and chronic hypoxia are not the same. Am J Respir Cric Care Mod, 2002.166 : 1537. 被引量：1
8Zwissler B. Der "kranke" rechte Ventrikel. Intensivmed, 2001, 38 : 264. 被引量：1
9Parole SK, Finer NN. Experimental and clinical effects of magnesium infusion in the treatment of neonatal pulmonary hypertension. Magnes Res, 1995.8 : 373. 被引量：1
10Nootens M, Schrader B, Kaufmann E, et al. Comparative acute et-fects of adenosine and prostacyclin in primary pulmonary hy pertension. Chest, 1995,107 : 54. 被引量：1
33rd World PAH Symposium. Pulmonary arterial hypertension: epidemiology, pathobiology, assessment and therapy [ J ]. J Am Coll Cardiol,2004,43 (12 Suppl S):1S-90S. 被引量：1
4Rubin LJ. American College of Chest Physicians. Diagnosis and management of pulmonary arterial hypertension: ACCP evidencebased clinical practice guidelines [ J ]. Chest,2004,126 : 1 - 92. 被引量：1
5Galie N,Torbicki A, Barst R, et al. ESC guidelines:guidelines on the diagnosis and treatment of pulmonary arterial hypertension [ J ].Eur Heart J,2004,25:2243 -2278. 被引量：1
6Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension [ J ]. J Am Coll Cardiol,43 (12) :5 -12. 被引量：1
7Mcgoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension [ J ]. Chest,2004,126:14 -34. 被引量：1
8McQuillan BM, Picard MH, Leavitt M, et al. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects [ J ]. Circulation, 2001,104 :2797 - 2802. 被引量：1
9Hoeper MM, Oudiz RJ, Peacock A, et al. End points and clinical trial designs in pulmonary arterial hypertension [ J ]. J Am Coll Cardiol,2004,43:48 - 55. 被引量：1
10Gali~ N,Hoeper MM,Humbert M ,et a/.Guidelines for the diagnosis and treatment of pulmonary hypertension:the task force for the diagnosis and treatment of pulmonaryhypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS),endorsed by the International Society of Heart and Lung Transplanta- tion (ISHLT)[J].Eur Heart J, 2009,30 (20) : 2493-2537. 被引量：1
